95 SAWYER ROAD, WALTHAM, MA
Shareholder votes
Other Events
Earnings Release
News, Reorganization Plan
Reports Full-Year 2024 Financial Results and Recent Corporate Updates
To Acquire Checkpoint Therapeutics
News, Material Contracts
Announces FDA Approval of UNLOXCYTTM (cosibelimab-ipdl)
Q1
FY 2024
Q3
Q2
FY 2023
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Definitive Merger Proxy Statement
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
S-8 POS
Post-Effective Amendment to Registration Statement